Haematology news

To celebrate Clinical Trials Day 2026, we brought our clinical and legal teams together, offering the Monash Office of the General Counsel a unique opportunity to experience the 'real-time' science behind the contracts.

Monash Health, in collaboration with Monash University, has reached a ground-breaking milestone in the treatment of autoimmune diseases, successfully treating the first lupus patient in Australia with CAR (Chimeric Antigen Receptor) T-cell therapy.

Congratulations to the School of Clinical Sciences at Monash Health staff who have been successful in the recent academic promotions round!

Professor Jake Shortt, the Head of Haematology Research at Monash’s School of Clinical Sciences at Monash Health, reviewed the science behind a clinical trial reported by Richardson et al on the activity of mezigdomide in multiple myeloma.

A collaboration between medicinal chemists, laboratory and clinician-scientists at Monash University and Peter MacCallum Cancer Centre developed a single drug that delivers a ‘one-two’ punch to several types of blood cancer in

Research by Haematologist Dr Maciej Tatarczuch found that presence or absence of certain genetic mutations in Marginal Zone Lymphoma tumour samples could inform doctors if the patient was likely to respond to Zanubrutinib.

From February, the newly established Cellular Therapies Service at Monash Health will be able to offer autologous stem cell transplantation (ASCT) to patients treated at Monash Health.